{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:11:51Z","timestamp":1781932311004,"version":"3.54.5"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["1053320231316\/ 218102085"],"award-info":[{"award-number":["1053320231316\/ 218102085"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016802","name":"Natural Science Foundation of Changzhou Municipality","doi-asserted-by":"publisher","award":["kq2208407"],"award-info":[{"award-number":["kq2208407"]}],"id":[{"id":"10.13039\/100016802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370772"],"award-info":[{"award-number":["82370772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370771"],"award-info":[{"award-number":["82370771"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40952"],"award-info":[{"award-number":["2023JJ40952"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejphar.2024.177197","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:05:36Z","timestamp":1733789136000},"page":"177197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Therapeutic targets of antidiabetic drugs and kidney stones: A druggable mendelian randomization study and experimental study in rats"],"prefix":"10.1016","volume":"987","author":[{"given":"Maolan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hequn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5320-9391","authenticated-orcid":false,"given":"Zewu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejphar.2024.177197_bib1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s10654-018-0426-4","article-title":"Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies","volume":"33","author":"Aune","year":"2018","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/STROKEAHA.122.040598","article-title":"Anti-epileptic drug target perturbation and intracranial aneurysm risk: mendelian randomization and colocalization study","volume":"54","author":"Bakker","year":"2023","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.ejphar.2024.177197_bib3","doi-asserted-by":"crossref","first-page":"e3003","DOI":"10.1210\/clinem\/dgac154","article-title":"Empagliflozin and decreased risk of nephrolithiasis: a potential new role for SGLT2 inhibition?","volume":"107","author":"Balasubramanian","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2024.177197_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177197_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177197_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177197_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation","volume":"36","author":"Carter","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ejphar.2024.177197_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2017.00006","article-title":"Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management","volume":"8","author":"Chaudhury","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177197_bib9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2021.0005","article-title":"Association of antihypertensive drug target genes with psychiatric disorders: a mendelian randomization study","volume":"78","author":"Chauquet","year":"2021","journal-title":"JAMA Psychiatr."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib10","doi-asserted-by":"crossref","first-page":"F137","DOI":"10.1152\/ajprenal.00047.2019","article-title":"Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-\u03b3-miR-23 axis","volume":"317","author":"Chen","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177197_bib11","first-page":"297","article-title":"Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives","volume":"4","author":"Chiarelli","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejphar.2024.177197_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/srep00139","article-title":"A phospholipidomic analysis of all defined human plasma lipoproteins","volume":"1","author":"Dashti","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177197_bib13","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177197_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000496208","article-title":"Association between dyslipidemia and nephrolithiasis risk in a Chinese population","volume":"103","author":"Ding","year":"2019","journal-title":"Urol. Int."},{"key":"10.1016\/j.ejphar.2024.177197_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150912","article-title":"Empagliflozin reduces renal calcium oxalate deposition in hyperoxaluria rats induced with ethylene glycol-ammonium chloride","volume":"737","author":"Duan","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41598-021-04036-7","article-title":"Different sites of actions make different responses to thiazolidinediones between mouse and rat models of fatty liver","volume":"12","author":"Ebihara","year":"2022","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177197_bib17","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1681\/ASN.2014060631","article-title":"A nomogram for the prediction of kidney stone recurrence","volume":"25","author":"Eisner","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177197_bib18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-020-20885-8","article-title":"A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits","volume":"12","author":"Foley","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2024.177197_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s11255-023-03784-x","article-title":"The association of dyslipidemia with kidney stone: result from the NHANES 2007-2020","author":"Gao","year":"2023","journal-title":"Int. Urol. Nephrol."},{"issue":"D1","key":"10.1016\/j.ejphar.2024.177197_bib21","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177197_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"R2","key":"10.1016\/j.ejphar.2024.177197_bib24","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177197_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejphar.2024.177197_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177197_bib27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00125-005-1753-z","article-title":"Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes","volume":"48","author":"Hiukka","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2024.177197_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110636","article-title":"Inhibition of AT1R\/IP3\/IP3R-mediated Ca(2+) release protects against calcium oxalate crystals-induced renal oxidative stress","volume":"382","author":"Hong","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"8","key":"10.1016\/j.ejphar.2024.177197_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084300","article-title":"Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL)","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177197_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73873","article-title":"Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study","volume":"10","author":"Huang","year":"2021","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.ejphar.2024.177197_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/nu14071339","article-title":"Dyslipidemia increases the risk of incident kidney stone disease in a large Taiwanese population follow-up study","volume":"14","author":"Hung","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2024.177197_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-020-00392-1","article-title":"Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation","author":"Khan","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2024.177197_bib33","article-title":"Kidney stones","volume":"2","author":"Khan","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177197_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177197_bib35","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00125-021-05424-4","article-title":"Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis","volume":"64","author":"Kristensen","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2024.177197_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/DMSO.S109216","article-title":"Practical combination therapy based on pathophysiology of type 2 diabetes","volume":"9","author":"Levin","year":"2016","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12933-023-02019-8","article-title":"SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study","volume":"22","author":"Li","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177197_bib38","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/jcp.27102","article-title":"Peroxisome proliferator-activated receptor \u03b3 modulates renal crystal retention associated with high oxalate concentration by regulating tubular epithelial cellular transdifferentiation","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177197_bib39","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00345-023-04360-9","article-title":"Increased renal uptake and urine excretion of oxidized LDL is possibly associated with formation of large calcium oxalate nephrolithiasis: a preliminary study","volume":"41","author":"Liu","year":"2023","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2024.177197_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ebiom.2019.10.059","article-title":"H19 promote calcium oxalate nephrocalcinosis-induced renal tubular epithelial cell injury via a ceRNA pathway","volume":"50","author":"Liu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2024.177197_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2022.12.088","article-title":"Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK\/NRF2 pathway","volume":"195","author":"Lu","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"4\u20135","key":"10.1016\/j.ejphar.2024.177197_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clinbiochem.2011.12.013","article-title":"Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography","volume":"45","author":"Lucero","year":"2012","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/1082-989X.7.1.83","article-title":"A comparison of methods to test mediation and other intervening variable effects","volume":"7","author":"MacKinnon","year":"2002","journal-title":"Psychol. Methods"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib44","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/s41598-017-01953-4","article-title":"Systematic evaluation for effects of urine pH on calcium oxalate crystallization, crystal-cell adhesion and internalization into renal tubular cells","volume":"7","author":"Manissorn","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177197_bib45","article-title":"Association between gestational diabetes mellitus and future risk of kidney stones","volume":"10","author":"Mao","year":"2022","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/00365590310008730","article-title":"Urinary stone disease in diabetes mellitus","volume":"37","author":"Meydan","year":"2003","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1016\/j.ejphar.2024.177197_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/2277-9175.164012","article-title":"Type 2 diabetes mellitus and renal stones","volume":"4","author":"Nerli","year":"2015","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.ejphar.2024.177197_bib48","article-title":"Sodium-glucose cotransporter 2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes","author":"Paik","year":"2024","journal-title":"JAMA Intern. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177197_bib49","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10654-023-01000-9","article-title":"Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study","volume":"38","author":"Qin","year":"2023","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12944-019-0957-z","article-title":"Phospholipids in lipoproteins: compositional differences across VLDL, LDL, and HDL in pregnant women","volume":"18","author":"Rauschert","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ije\/dyr233","article-title":"Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease","volume":"41","author":"Relton","year":"2012","journal-title":"Int. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177197_bib52","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41597-023-01949-y","article-title":"Quality control and removal of technical variation of NMR metabolic biomarker data in \u223c120,000 UK Biobank participants","volume":"10","author":"Ritchie","year":"2023","journal-title":"Sci. Data"},{"issue":"16","key":"10.1016\/j.ejphar.2024.177197_bib54","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177197_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177197_bib56","doi-asserted-by":"crossref","first-page":"344","DOI":"10.23736\/S0031-0808.21.04517-1","article-title":"Metabolic syndrome and stone disease","volume":"64","author":"Soligo","year":"2022","journal-title":"Panminerva Med."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177197_bib57","article-title":"Epidemiology of kidney stones","volume":"11","author":"Stamatelou","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"15","key":"10.1016\/j.ejphar.2024.177197_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511955","article-title":"PPARG: a novel target for yellow tea in kidney stone prevention","volume":"24","author":"Su","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177197_bib59","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.kint.2020.01.042","article-title":"Fatty acid-binding protein 4 downregulation drives calcification in the development of kidney stone disease","volume":"97","author":"Taguchi","year":"2020","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177197_bib60","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2337\/diab.39.9.1017","article-title":"Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM","volume":"39","author":"Taskinen","year":"1990","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177197_bib61","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1523-1755.2005.00516.x","article-title":"Diabetes mellitus and the risk of nephrolithiasis","volume":"68","author":"Taylor","year":"2005","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177197_bib62","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.urology.2014.02.074","article-title":"Type-2 diabetes and kidney stones: impact of diabetes medications and glycemic control","volume":"84","author":"Torricelli","year":"2014","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.ejphar.2024.177197_bib63","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/dom.14451","article-title":"Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"23","author":"Tsapas","year":"2021","journal-title":"Diabetes Obes. Metabol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177197_bib64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2015.07.041","article-title":"EAU guidelines on interventional treatment for urolithiasis","volume":"69","author":"T\u00fcrk","year":"2016","journal-title":"Eur. Urol."},{"issue":"Pt D","key":"10.1016\/j.ejphar.2024.177197_bib65","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijsu.2016.11.018","article-title":"Animal models of urinary stone disease","volume":"36","author":"Tzou","year":"2016","journal-title":"Int. J. Surg."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177197_bib66","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"issue":"Suppl. 16","key":"10.1016\/j.ejphar.2024.177197_bib67","first-page":"S165","article-title":"Urinary pH and stone formation","volume":"23","author":"Wagner","year":"2010","journal-title":"J. Nephrol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177197_bib68","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/ije\/dyx207","article-title":"Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities","volume":"46","author":"Walker","year":"2017","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177197_bib69","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4982","article-title":"Recent advances on the mechanisms of kidney stone formation","volume":"48","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177197_bib70","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/aje\/kwp411","article-title":"Presence of gallstones or kidney stones and risk of type 2 diabetes","volume":"171","author":"Weikert","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"D1","key":"10.1016\/j.ejphar.2024.177197_bib71","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2024.177197_bib72","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1476-511X-10-143","article-title":"Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS","volume":"10","author":"Wood","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejphar.2024.177197_bib73","article-title":"Resveratrol attenuates oxalate-induced renal oxidative injury and calcium oxalate crystal deposition by regulating TFEB-induced autophagy pathway","volume":"9","author":"Wu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177197_bib74","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.2337\/dc22-0323","article-title":"SGLT2 inhibition, choline metabolites, and cardiometabolic diseases: a mediation mendelian randomization study","volume":"45","author":"Xu","year":"2022","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177197_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003897","article-title":"Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: a mendelian randomization analysis","volume":"19","author":"Yarmolinsky","year":"2022","journal-title":"PLoS Med."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177197_bib76","first-page":"1323","article-title":"The protective role of corilagin on renal calcium oxalate crystal-induced oxidative stress, inflammatory response, and apoptosis via PPAR-\u03b3 and PI3K\/Akt pathway in rats","volume":"68","author":"Yuan","year":"2021","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2024.177197_bib77","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2021.08.010","article-title":"Assessing causal associations of obesity and diabetes with kidney stones using Mendelian randomization analysis","volume":"134","author":"Yuan","year":"2021","journal-title":"Mol. Genet. Metabol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177197_bib78","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat. Genet."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924008872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924008872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T17:07:39Z","timestamp":1735319259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924008872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":78,"alternative-id":["S0014299924008872"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177197","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targets of antidiabetic drugs and kidney stones: A druggable mendelian randomization study and experimental study in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177197"}}